title: Correction regarding data on blinatumomab-associated seizures.
authors.affiliation: Department of Internal Medicine II, Division of Hematology and Medical Oncology, Würzburg University Medical Centre, Oberdürrbacher Strasse 6, Würzburg 97080, Germany.
authors.forename: Max S
authors.initials: MS
authors.lastname: Topp
authors.affiliation: Global Clinical Development, Amgen Inc., 1 Amgen Center Drive 38-2-A, Thousand Oaks, California 91320, USA.
authors.forename: Zachary
authors.initials: Z
authors.lastname: Zimmerman
authors.affiliation: Department of Leukemia, University of Texas MD Anderson Cancer Center, Unit 428, PO Box 301402, 1515 Holcombe Boulevard, Houston, Texas 77030-1402, USA.
authors.forename: Hagop M
authors.initials: HM
authors.lastname: Kantarjian
mesh_terms: D018033:Antibodies, Bispecific; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D012640:Seizures
chemical_list: D018033:Antibodies, Bispecific; C510808:blinatumomab